VRC01LS

VRC01LS · National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC), NIH

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VRC01LS, covering 2021-01-08 to 2021-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants [Phase 1]

See pricing